• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
YANG Xinping,LIAN Qi,YU Boyang,LIU Jihua,LIU Xiufeng.Coagulation factor Ⅻ: a new target for antithrombotic drug[J].Journal Of Pharmaceutical Research,2022,41(11):731-736[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2051times   Download 2213次 QR Code for this article
Scan with your phone!
凝血因子Ⅻ—抗血栓形成的新靶点
杨鑫萍,连琪,余伯阳,刘吉华,刘秀峰
Font:Larger+|Default|Smaller-
(中国药科大学江苏省中药评价与转化重点实验室,中国药科大学中药可追溯与标准化研究中心,江苏 南京 210009)
摘要:
随着血栓性疾病发病率的逐年上升,人类的健康受到了严重危害。目前常用治疗血栓的药物大都存在着出血风险。为寻求有效且能避免出血的抗血栓治疗靶点,凝血途径中每一个因子都被不同程度的开发。在这些因子中,凝血因子Ⅻ(factor Ⅻ,FⅫ)脱颖而出。大量研究表明,FⅫ的功能缺失可以抑制血栓形成而不会引起自发性出血。因此,本文以FⅫ作为抗血栓药物新靶点为主题,对FⅫ在血栓形成中的作用及其作为抗血栓药物靶点的研究进展做一综述。
关键词:  血栓性疾病  凝血因子Ⅻ  抗血栓形成  新靶点
DOI:10.13506/j.cnki.jpr.2022.11.008
基金项目:国家自然科学基金(No.82141207)
Publication Date:November 25, 2022
Coagulation factor Ⅻ: a new target for antithrombotic drug
YANG Xinping,LIAN Qi,YU Boyang,LIU Jihua,LIU Xiufeng
(Jiangsu Key Laboratory of Evaluation and Transformation of Traditional Chinese Medicine, Research Center for Traceability and Standardization of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing 210009, China)
Abstract:
People's health is under serious threat with the incidence of thrombotic diseases increasing year by year. Most of the drugs currently commonly used to treat thrombosis are associated with bleeding risks. Each factor in the clotting pathway has been developed to varying degrees in order to find effective antithrombotic therapeutic targets that can avoid bleeding. Among these factors, coagulation factor Ⅻ (FⅫ) stands out because numerous studies have shown that blocking FⅫ's function prevents thrombosis without causing spontaneous bleeding. Therefore, with the theme of FⅫ as a new target of antithrombotic drugs, this paper reviewed the role of FⅫ in thrombosis and its research progress as a target of antithrombotic drugs.
Key words:  Thrombotic diseases  Coagulation Factor Ⅻ  Antithrombotic  New target
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.